Evidence map›Paper›PMID 40296872›Full record

ArticleFrontiers in genetics2025

Genetic variants in

Rebeca I Montero, Cinthia L Dionicio, Gino Noris, Maricela Piña-Pozas, Carla Santana, Rocío Gómez

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rebeca I Montero *Biología Molecular Diagnóstica, Querétaro, Qro, Mexico.
Cinthia L Dionicio *Biología Molecular Diagnóstica, Querétaro, Qro, Mexico.
Gino NorisBiología Molecular Diagnóstica, Querétaro, Qro, Mexico.
Maricela Piña-PozasCentro de Información para Decisiones en Salud Pública, Instituto Nacional de Salud Pública (INSP), Mexico City, Mexico.
Carla SantanaBiología Molecular Diagnóstica, Querétaro, Qro, Mexico.
Rocío GómezDepartamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since host genetics is one of the primary factors contributing to COVID-19 susceptibility and its clinical progression, several studies have focused on analysing the implications of genetic polymorphisms associated with COVID-19. These studies particularly emphasise on common variants in genes that are involved in the viral mechanism of host entry and in the host's response to infection. In this study, we explored the participation of 24 single nucleotide polymorphisms located on the

Indexed as

COVID-19gene polymorphismrs4303795rs75603675rs8134378SARS-CoV-2 infectionTMPRSS2

Identifiers

PMID40296872
PMCPMC12034715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.